Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Composition for overcoming resistance to EGFR-targeting agent

Composition for overcoming resistance to EGFR-targeting agent

US Patent 11548915 · Granted Jan 10, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Show case2025
Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the sa2025
Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the sa2025
CH3 domain variant pair inducing formation of heterodimer of heavy chain constan2025
Method and apparatus for visual coding2025
Human antibody having high affinity to human IL-4 receptor alpha2025
Pharmaceutical composition for preventing and treating eye diseases, containing 2023
Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the sa2023
Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the sa2023
Display device2023
IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constan2022
IL-21 (heterodimeric Fc-fused IL-21) fused to immunoglobulin heavy chain constan2022